www.fdanews.com/articles/165478-improper-procedures-lead-to-483-for-pet-drugmaker

Improper Procedures Lead To 483 for PET Drugmaker

June 27, 2014

The FDA chided positron emission tomography (PET) drug manufacturer IBA Molecular North America for not properly handling complaints and quality production.
Drug GMP Report